The second National Academic Conference on Bacterial and Fungal Infections of Chinese Medical Association was successfully held in Guangzhou, July 29-31, 2022. The academic report of the conference...
On June 28, the “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crab Marine Biomedicine Industrial Park” invested and c...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
The genomic sequences of most viruses have been known. Nucleic acid probes which are short segments of DNA designed to hybridize with complementary viral DNA or RNA segments . The polymerase chain...
Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...